Product Information
CYPROHEPTADINE 2 MG/5 ML SYRUP is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0419 per ML under NDC 64980050448. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jun 28, 2006. Its Orange Book therapeutic-equivalence code is AA.
Strength
2 mg/5mL
Manufacturer
Rising Pharma Holdings Inc.NDC
64980050448
Classification
Generic
Dosage Form
SYRUP
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CYPROHEPTADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040668FDA Approved
6/28/2006
TE Code
AA
On Market Since
7/10/2006
Price Statistics
The NADAC for CYPROHEPTADINE 2 MG/5 ML SYRUP has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 55.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0419 per ML |
|---|---|
| All-time high | $0.0971 (Feb 12, 2014) |
| All-time low | $0.0377 (Jan 22, 2025) |
| 52-week high | $0.0423 |
| 52-week low | $0.0404 |
| Median price | $0.0741 |
| Average price | $0.0673 |
| Largest weekly change | +27.4% (Mar 18, 2020) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Cyproheptadine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cyproheptadine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CYPROHEPTADINE 2 MG/5 ML SYRUP?
The current National Average Drug Acquisition Cost (NADAC) for CYPROHEPTADINE 2 MG/5 ML SYRUP, manufactured by Rising Pharma Holdings Inc., is $0.0419 per ML (NDC 64980050448), effective Sep 30, 2026.
How has the price of CYPROHEPTADINE 2 MG/5 ML SYRUP changed over time?
Over the history we have for it, the NADAC for CYPROHEPTADINE 2 MG/5 ML SYRUP has declined 55.0%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CYPROHEPTADINE 2 MG/5 ML SYRUP?
Since Nov 28, 2013, the NADAC for CYPROHEPTADINE 2 MG/5 ML SYRUP has ranged from a low of $0.0377 (Jan 22, 2025) to a high of $0.0971 (Feb 12, 2014), with a median of $0.0741 per ML.
Are there cheaper alternatives to CYPROHEPTADINE 2 MG/5 ML SYRUP?
No other NADAC-published product currently shares the active ingredient and strength of CYPROHEPTADINE 2 MG/5 ML SYRUP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CYPROHEPTADINE 2 MG/5 ML SYRUP?
CYPROHEPTADINE 2 MG/5 ML SYRUP (NDC 64980050448) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.